Observational studyBMJ open2019

Clinical characteristics and lipid lowering treatment of patients initiated on proprotein convertase subtilisin-kexin type 9 inhibitors: a nationwide cohort study.

Jakob Solgaard Jensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.